Weekly Quick Hits (BHCR) – Week of July 24, 2023

Published on : Published by : Mark Terry

Children’s Cancer Foundation Awards went out to 11 pediatric cancer researchers in the Baltimore-Washington region, and a number of companies reported their quarterly finances. It was a busy week for life science news in the Capital Region. Here’s a look.

Weekly Quick Hits (BioHealth Capital Region) – Week of July 17, 2023

Published on : Published by : Alex Keown

A strong revenue stream is essential for thriving biopharma companies. Despite a struggling economy, several companies within the BioHealth Capital Region are successfully raising capital to support development of new therapeutics for multiple disorders, while others continue to advance their own experimental assets. 

Bio-Trac Rolls Out Comprehensive Antibody Validation Workshop Featuring Hands-on Lab Exercises

Published on : Published by : Cat Thoreson

Understanding and validating antibodies’ role and function is an essential skill in today’s research landscape. Recognizing this need, Bio-Trac has designed a unique two-day workshop focused on antibody validation. This program is an invaluable resource for scientists, offering practical, hands-on experience in the field, and promising to significantly enhance the reliability of research outcomes. Dive into the details of this innovative workshop and discover how it’s shaping the future of biotech research.

Capra Biosciences on the Leading Wave of Sustainable Biomanufacturing

Published on : Published by : Mark Terry

Capra Biosciences, based in Manassas, Va., is building the foundation — literally, in many ways — to grow in the area of synthetic biology and biomanufacturing. Working with its patented bioreactor technology, the company is manufacturing traditionally petroleum-based chemicals using biological processes. The company’s first product is a 100% petroleum-free Retinol.

LUMINOAH RAISES $6M TO REVOLUTIONIZE TUBE FEEDING

Published on : Published by : BioBuzz Media

Luminoah Inc., a medical technology company dedicated to improving the standard of care for patients requiring enteral nutrition, has closed a $6 million Series A funding round led by Fry’s Path Capital, with participation from Sands Capital, CAV Angels, Virginia Venture Partners, and 757 Angels. The funding will be used to complete the development of Luminoah’s portable, data-driven enteral nutrition system.